Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system

BackgroundArrhythmias are prevalent cardiac disorders with significant impacts on patient quality of life and mortality. Amiodarone, a class III antiarrhythmic agent, is widely used to manage both atrial and ventricular arrhythmias due to its efficacy in prolonging the cardiac action potential and i...

Full description

Saved in:
Bibliographic Details
Main Authors: Jingrong Yang, Mengfan You, Jingxin Wang, Rongfei Sun, Lili Han, Xiaonan Liu, Kaibin Niu, Kaidi Xing, Juanping Sun, Wenge Su, Yifei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
amiodarone
oral
intravenous
FDA
adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1517616/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1517616/full

Similar Items